Company: | Paul McBarron, (908) 517-7330, pmcbarron@cyclacel.com |
Investor Relations: | Grace Kim, IR@cyclacel.com |
The Investor Relations website contains information about Cyclacel Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ...
As a clinical-stage, biopharmaceutical company, we develop innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics and mitosis ...
People also ask
What is a Cyclacel?
What is the email format for Cyclacel Pharma?
Investor Relations: Russo Partners LLC, Robert Flamm, (212) 845-4226, robert.flamm@russopartnersllc.com. © Copyright 2014 Cyclacel Pharmaceuticals, Inc. All ...
... investing for the long-haul, we have you covered. Delivered Mondays. All Text Fields Are Required. Thanks for submitting! Investor Relations · Contact · Careers ...
Roth Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service ...
Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for ...